Gregory Knutson serves as Executive at U.S. Stem Cell, Inc., where they oversee executive responsibilities. Since joining the company, Gregory Knutson has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 25, 2022 involved receiving (via award) 2,500,000 shares valued at $0.
Gregory Knutson currently holds 29,175,000 shares of U.S. Stem Cell, Inc. (USRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Knutson has been a net neutral trader of USRM stock. They have purchased $0 and sold $0 worth of shares.
Gregory Knutson's most recent insider trade was on Apr 25, 2022, when they sold 2,500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 2, 2021 | USRM | $9.4K | Other | 187,575 | $0.05 | Discretionary |
| Oct 5, 2020 | USRM | $0 | Other | 2,035,820 | $N/A | Discretionary |
| Apr 1, 2020 | USRM | $0 | Other | 1,445,647 | $N/A | Discretionary |